{"id":458,"date":"2022-08-02T07:11:29","date_gmt":"2022-08-02T07:11:29","guid":{"rendered":"https:\/\/mpelembe.net\/?p=458"},"modified":"2022-08-02T07:12:11","modified_gmt":"2022-08-02T07:12:11","slug":"66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner","status":"publish","type":"post","link":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/","title":{"rendered":"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner"},"content":{"rendered":"

A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). It was concluded that OCT-guided diagnosis, when compared to a standard punch biopsy could reduce the number of consultations and invasive procedures by a massive 66%. Continue reading<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company thatRead More…<\/a><\/p>\n","protected":false},"author":1,"featured_media":459,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAowu7GVCw:productID":"","_crdt_document":"","activitypub_content_warning":"","activitypub_content_visibility":"","activitypub_max_image_attachments":3,"activitypub_interaction_policy_quote":"anyone","activitypub_status":"","footnotes":""},"categories":[19],"tags":[596,597,598,599,600,1056,601,656,602,603,604,605,1055,862,606,607,723],"class_list":["post-458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-basal-cell-carcinoma","tag-biopsy","tag-clinical-medicine","tag-health-care","tag-laser-medicine","tag-medical-diagnosis","tag-medical-equipment","tag-medical-specialties","tag-medicine","tag-michelson-diagnostics","tag-optical-coherence-tomography","tag-optical-imaging","tag-optics","tag-rtt","tag-skin-cancer","tag-tomography","tag-united-kingdom"],"featured_image_src":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg","blog_images":{"medium":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1-300x300.jpg","large":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg"},"ams_acf":[],"yoast_head":"\n66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner - Mpelembe Network<\/title>\n<meta name=\"description\" content=\"Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the white population in their lifetime\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner - Mpelembe Network\" \/>\n<meta property=\"og:description\" content=\"Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the white population in their lifetime\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/\" \/>\n<meta property=\"og:site_name\" content=\"Mpelembe Network\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-02T07:11:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-02T07:12:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/#\\\/schema\\\/person\\\/2421ebbf3150931b1066b10a196d7608\"},\"headline\":\"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner\",\"datePublished\":\"2022-08-02T07:11:29+00:00\",\"dateModified\":\"2022-08-02T07:12:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/\"},\"wordCount\":87,\"image\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mpelembe.net\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/VivoSight_1.jpg\",\"keywords\":[\"Basal-cell carcinoma\",\"Biopsy\",\"Clinical medicine\",\"Health care\",\"Laser medicine\",\"Medical diagnosis\",\"Medical equipment\",\"Medical specialties\",\"Medicine\",\"Michelson Diagnostics\",\"Optical coherence tomography\",\"Optical imaging\",\"Optics\",\"RTT\",\"Skin cancer\",\"Tomography\",\"United Kingdom\"],\"articleSection\":[\"Healthcare\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/\",\"url\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/\",\"name\":\"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner - Mpelembe Network\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mpelembe.net\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/VivoSight_1.jpg\",\"datePublished\":\"2022-08-02T07:11:29+00:00\",\"dateModified\":\"2022-08-02T07:12:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/#\\\/schema\\\/person\\\/2421ebbf3150931b1066b10a196d7608\"},\"description\":\"Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the white population in their lifetime\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mpelembe.net\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/VivoSight_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mpelembe.net\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/VivoSight_1.jpg\",\"width\":400,\"height\":400,\"caption\":\"Professor Klara Mosterd performing an OCT scan on a patient\u2019s lesion.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mpelembe.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/#website\",\"url\":\"https:\\\/\\\/mpelembe.net\\\/\",\"name\":\"Mpelembe Network\",\"description\":\"Collaboration Platform\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mpelembe.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mpelembe.net\\\/#\\\/schema\\\/person\\\/2421ebbf3150931b1066b10a196d7608\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c66a2765397adfb52418f6f2310640167a0af23ce662da1b68c8a0b8650de556?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c66a2765397adfb52418f6f2310640167a0af23ce662da1b68c8a0b8650de556?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c66a2765397adfb52418f6f2310640167a0af23ce662da1b68c8a0b8650de556?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/mpelembe.net\"],\"url\":\"https:\\\/\\\/mpelembe.net\\\/index.php\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner - Mpelembe Network","description":"Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the white population in their lifetime","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/","og_locale":"en_US","og_type":"article","og_title":"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner - Mpelembe Network","og_description":"Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the white population in their lifetime","og_url":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/","og_site_name":"Mpelembe Network","article_published_time":"2022-08-02T07:11:29+00:00","article_modified_time":"2022-08-02T07:12:11+00:00","og_image":[{"width":400,"height":400,"url":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#article","isPartOf":{"@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/"},"author":{"name":"admin","@id":"https:\/\/mpelembe.net\/#\/schema\/person\/2421ebbf3150931b1066b10a196d7608"},"headline":"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner","datePublished":"2022-08-02T07:11:29+00:00","dateModified":"2022-08-02T07:12:11+00:00","mainEntityOfPage":{"@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/"},"wordCount":87,"image":{"@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#primaryimage"},"thumbnailUrl":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg","keywords":["Basal-cell carcinoma","Biopsy","Clinical medicine","Health care","Laser medicine","Medical diagnosis","Medical equipment","Medical specialties","Medicine","Michelson Diagnostics","Optical coherence tomography","Optical imaging","Optics","RTT","Skin cancer","Tomography","United Kingdom"],"articleSection":["Healthcare"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/","url":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/","name":"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner - Mpelembe Network","isPartOf":{"@id":"https:\/\/mpelembe.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#primaryimage"},"image":{"@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#primaryimage"},"thumbnailUrl":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg","datePublished":"2022-08-02T07:11:29+00:00","dateModified":"2022-08-02T07:12:11+00:00","author":{"@id":"https:\/\/mpelembe.net\/#\/schema\/person\/2421ebbf3150931b1066b10a196d7608"},"description":"Approximately 75% of skin cancers diagnosed in the UK are basal cell carcinomas. It is the most common form of skin cancer that is rapidly increasing, with it affecting one in five people in the white population in their lifetime","breadcrumb":{"@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#primaryimage","url":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg","contentUrl":"https:\/\/mpelembe.net\/wp-content\/uploads\/2022\/08\/VivoSight_1.jpg","width":400,"height":400,"caption":"Professor Klara Mosterd performing an OCT scan on a patient\u2019s lesion."},{"@type":"BreadcrumbList","@id":"https:\/\/mpelembe.net\/index.php\/66-of-diagnostic-biopsies-for-common-skin-cancer-can-be-avoided-using-michelson-diagnostics-vivosight-oct-laser-scanner\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mpelembe.net\/"},{"@type":"ListItem","position":2,"name":"66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner"}]},{"@type":"WebSite","@id":"https:\/\/mpelembe.net\/#website","url":"https:\/\/mpelembe.net\/","name":"Mpelembe Network","description":"Collaboration Platform","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mpelembe.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/mpelembe.net\/#\/schema\/person\/2421ebbf3150931b1066b10a196d7608","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c66a2765397adfb52418f6f2310640167a0af23ce662da1b68c8a0b8650de556?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c66a2765397adfb52418f6f2310640167a0af23ce662da1b68c8a0b8650de556?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c66a2765397adfb52418f6f2310640167a0af23ce662da1b68c8a0b8650de556?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/mpelembe.net"],"url":"https:\/\/mpelembe.net\/index.php\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/posts\/458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/comments?post=458"}],"version-history":[{"count":1,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/posts\/458\/revisions"}],"predecessor-version":[{"id":460,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/posts\/458\/revisions\/460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/media\/459"}],"wp:attachment":[{"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/media?parent=458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/categories?post=458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mpelembe.net\/index.php\/wp-json\/wp\/v2\/tags?post=458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}